BPI Labs RX
FDA Approved Drugs

BPI Labs RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 12
  • Latest Approval Date Apr 30, 2026
  • Data Source FDA
  • First Approval Date Jul 29, 2014
All
14
View
Discontinued
2
View
RX
12
View
Company Overview

Company

BPI Labs RX

Country

U.S.A

Email

Social Profiles

LinkedIn
Company Snapshot

BPI Labs RX

97 S. Red Willow Rd., Evanston, Wyoming 82930

U.S.A

www.bpilabs.com/ View on Map
FDA Approved Drug Records ( 12 records )
2018
21 Jun
RX Application: 207987

Drug Name

ABLYSINOL

Product Number

2

Dosage Form

-

Strength

99% (5ML)

Approval Date

2018-06-21

207987 / 2

Active Ingredient

DEHYDRATED ALCOHOL

Application Number

207987

Product Number

2

Dosage Form

-

Strength

99% (5ML)

Approval Date

2018-06-21

Regulatory Status

RX

2014
29 Jul
RX Application: 205029

Drug Name

EPINEPHRINE

Product Number

1

Dosage Form

-

Strength

1MG/ML (1MG/ML)

Approval Date

2014-07-29

205029 / 1

Active Ingredient

EPINEPHRINE

Application Number

205029

Product Number

1

Dosage Form

-

Strength

1MG/ML (1MG/ML)

Approval Date

2014-07-29

Regulatory Status

RX

2022
04 Feb
RX Application: 205029

Drug Name

EPINEPHRINE

Product Number

2

Dosage Form

-

Strength

10MG/10ML (1MG/ML)

Approval Date

2022-02-04

205029 / 2

Active Ingredient

EPINEPHRINE

Application Number

205029

Product Number

2

Dosage Form

-

Strength

10MG/10ML (1MG/ML)

Approval Date

2022-02-04

Regulatory Status

RX

2024
14 Feb
RX Application: 205029

Drug Name

EPINEPHRINE

Product Number

4

Dosage Form

-

Strength

30MG/30ML (1MG/ML)

Approval Date

2024-02-14

205029 / 4

Active Ingredient

EPINEPHRINE

Application Number

205029

Product Number

4

Dosage Form

-

Strength

30MG/30ML (1MG/ML)

Approval Date

2024-02-14

Regulatory Status

RX

2024
04 Mar
RX Application: 205029

Drug Name

EPINEPHRINE

Product Number

5

Dosage Form

-

Strength

1MG/ML (1MG/ML)

Approval Date

2024-03-04

205029 / 5

Active Ingredient

EPINEPHRINE

Application Number

205029

Product Number

5

Dosage Form

-

Strength

1MG/ML (1MG/ML)

Approval Date

2024-03-04

Regulatory Status

RX

2026
30 Apr
RX Application: 220046

Drug Name

FLUORESCEIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

Approval Date

2026-04-30

220046 / 1

Active Ingredient

FLUORESCEIN SODIUM

Application Number

220046

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

Approval Date

2026-04-30

Regulatory Status

RX

2020
08 May
RX Application: 209197

Drug Name

MELPHALAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2020-05-08

209197 / 1

Active Ingredient

MELPHALAN HYDROCHLORIDE

Application Number

209197

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2020-05-08

Regulatory Status

RX

2023
01 Jun
RX Application: 214283

Drug Name

MYCOPHENOLATE MOFETIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2023-06-01

214283 / 1

Active Ingredient

MYCOPHENOLATE MOFETIL HYDROCHLORIDE

Application Number

214283

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2023-06-01

Regulatory Status

RX

2023
06 Oct
RX Application: 216977

Drug Name

NALOXONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2023-10-06

216977 / 1

Active Ingredient

NALOXONE HYDROCHLORIDE

Application Number

216977

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2023-10-06

Regulatory Status

RX

2017
27 Nov
RX Application: 206677

Drug Name

PENTOBARBITAL SODIUM

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

2017-11-27

206677 / 1

Active Ingredient

PENTOBARBITAL SODIUM

Application Number

206677

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

2017-11-27

Regulatory Status

RX

2025
16 Oct
RX Application: 219606

Drug Name

TRIMETHOBENZAMIDE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2025-10-16

219606 / 1

Active Ingredient

TRIMETHOBENZAMIDE HYDROCHLORIDE

Application Number

219606

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2025-10-16

Regulatory Status

RX

2017
29 Dec
RX Application: 207341

Drug Name

ZOLEDRONIC ACID

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/5ML

Approval Date

2017-12-29

207341 / 1

Active Ingredient

ZOLEDRONIC ACID

Application Number

207341

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/5ML

Approval Date

2017-12-29

Regulatory Status

RX

Related Databases
  • FDA Inspections
    3 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    14 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
12 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABLYSINOL

Application Number

207987

Product Number

2

Active Ingredient

DEHYDRATED ALCOHOL

Dosage Form

-

Strength

99% (5ML)

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.